AustraliaHealth

Recce Pharmaceuticals (ASX:RCE) highlights a US$66.9 billion United States health strategy supporting antimicrobial resistance and clinical trials.

Dimerix (ASX:DXB) acquired a Phase 2-ready acute kidney injury candidate named DMX-652 for US$5 million.

Foresta Group Holdings (ASX:FGH) secured patent acceptance in Japan for its proprietary pine chemical extraction technology.

SomnoMed (ASX:SOM) announced Co-CEO Amrita Blickstead stepped down on July 27, leaving Karen Borg to lead the business globally.

Botanix Pharmaceuticals (ASX:BOT) generated $10.1 million in net revenue for the fourth quarter of fiscal 2026.

Imugene (ASX:IMU) CEO Leslie Chong has stepped down after nearly 11 years of service.

Imricor Medical Systems (ASX:IMR) launched its commercial rollout in the United States after securing its first hospital customer.

Radiopharm Theranostics (ASX:RAD) secured $12.5 million in fresh capital through an institutional raising.

EBR Systems (ASX:EBR) released a statement addressing online speculation after two patients implanted with its WiSE system.

Resonance Health (ASX:RHT) generated $14.3 million in cash receipts for FY26 while maintaining positive operating cash flow each quarter.

Little Green Pharma (ASX:LGP) CFO Paula Butler has tendered her resignation, effective July 31.

Austco Healthcare (ASX:AHC) secured a $4.2 million maintenance contract for the Jurong Health Complex in Singapore.